Masonic Cancer Center, University Of Minnesota

This study tested whether adding an experimental drug (VIC-1911) to standard medications can prevent graft-versus-host disease (GVHD) and relapse in adults with blood cancers like leukemia or lymphoma who receive a stem cell transplant. Sixteen participants were enrolled. The goa…

This study tested whether two special drinks can help the body remove harmful chemicals from the environment, including cancer-causing agents. The trial involved 300 healthy adults, both smokers and non-smokers. Researchers measured toxin levels in urine to see if the drinks impr…

This early-phase study tested a new drug called HCW9218 in 18 people with advanced solid tumors (except pancreatic and brain cancers) who had already tried at least two other treatments. The drug is designed to both activate the immune system and block signals that help tumors gr…

This study offered a radioactive drug called 131I-MIBG to 15 people with advanced neuroblastoma or pheochromocytoma who had run out of standard options. The goal was to see if it could ease symptoms and shrink tumors, while tracking side effects. Participants received a dose base…

This study looked at whether physical therapy can improve arm, shoulder, and hand problems that some people develop after breast cancer surgery. It involved 135 women and men who had surgery to remove breast cancer and at least one lymph node. The goal was to see if therapy helps…

This study tested whether a fully remote, telehealth-based approach can work for studying how different cigarette filter ventilation levels affect smoking habits and exposure to harmful chemicals. 64 adult smokers participated from home, mailing in samples and reporting data via …

This study tested whether the amount of sugar in cigarette tobacco changes how appealing or addictive the cigarettes are. Thirty adult smokers tried cigarettes with different sugar levels and answered questions about their experience. The goal was to see if lower-sugar cigarettes…